The Treatment of Attention-Deficit Hyperactivity Disorder: An Annotated Bibliography and Critical Appraisal of Published Systematic Reviews and Metaanalyses
Free accessReview articleFirst published online December, 1999
The Treatment of Attention-Deficit Hyperactivity Disorder: An Annotated Bibliography and Critical Appraisal of Published Systematic Reviews and Metaanalyses
The Agency for Health Care Policy and Research charged the McMaster Evidence-based Practice Center with conducting a comprehensive systematic review of the literature on the treatment of attention-deficit hyperactivity disorder (ADHD), with input from various groups of stakeholders. One strategy used to avoid duplication of work included a critical appraisal of existing systematic reviews and metaanalyses.
Objective:
To identify and appraise published metaanalyses and systematic reviews on the treatment of ADHD and to produce an annotated bibliography.
Data Sources:
Medline, Cumulative Index in Nursing and Allied Health (CINAHL), Healthstar, Psycinfo, and Embase were searched to September 1998; the Cochrane Database (1998 issue 3), selected Internet sites, and the files of investigators were also reviewed.
Study Selection:
Review articles described as systematic reviews or metaanalyses or including a Methods section were identified independently by 3 reviewers.
Data Extraction:
Two reviewers extracted, by consensus, relevant information on the name, methodological quality, ADHD-related aspects (comorbid disorders, family characteristics) of those reviews; data on the population, study setting, interventions, and outcomes evaluated by the reviews were also retrieved.
Results:
Thirteen reviews, published from 1982 to 1998, were included. Eight included metaanalysis and 5 a qualitative review. Non-pharmacological treatments were mentioned in 6 reviews and combination therapies in 3. One review focused on the treatment of adults. Forty-seven drugs and 20 adverse effects were mentioned. Most reviews had major methodological flaws.
Conclusions:
Most published systematic reviews and metaanalyses on the treatment of ADHD have limited value for guiding clinical, policy, and research decisions. A rigorous, systematic review following established methodological criteria is warranted.
American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1997;36(Suppl 10):85S–121S.
2.
GoldmanLSGenelMBezmanRJSlanetzPJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA1998;279:1100–1107.
3.
BarkleyRA. Attention-deficit/hyperactivity disorder. In: MashEJBarkleyRA, editors. Child psychopathology. New York: Guilford; 1996. p 63–112.
4.
WeinbergWABrumbackRA. The myth of attention-deficit-hyperactivity disorder: Symptoms resulting from multiple causes. J Child Neurol1992;7:431–45.
JadadARCookDJJonesAKlassenTPTugwellPMoherM. Methodology and reports of systematic reviews and meta-analysis: A comparison of Cochrane reviews with articles published in paper-based journals. JAMA1998;280:278–9.
9.
Berlin JA, for the University of Pennsylvania Meta-analysis Blinding Study Group. Does blinding of readers affect the results of meta-analyses?Lancet1997;350:185–6.
10.
OxmanADGuyattGH. Validation of an index of the quality of review articles. J Clin Epidemiol1991;44:1272–8.
11.
JadadARMcQuayHJ. Meta-analysis to evaluate analgesic interventions: A systematic qualitative review of their methodology. J Clin Epidemiol1996;49:235–43.
12.
BarnesDEBeroLA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA1998;279:1566–70.
13.
DuPaulGJEckertTL. The effects of school-based interventions for attention deficit hyperactivity disorder: A meta-analysis. School Psychology Review1997;26:5–27.
14.
KavaleK. The efficacy of stimulant drug treatment for hyperactivity: A metaanalysis. Journal of Learning Disabilities1982;15280–9.
15.
KavaleK AFornessSR. Hyperactivity and diet treatment: A meta-analysis of the Feingold hypothesis. Journal of Learning Disabilities1983;16:324–30.
16.
LosierBJMcGrathPJKleinRM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: A meta-analytic review. J Child Psychol Psychiatry1996;37:971–87.
17.
OttenbacherK JCooperHM. Drug treatment of hyperactivity in children. Dev Med Child Neurology1983;25:358–66.
18.
SchacharRTannockR. Childhood hyperactivity and psychostimulants: A review of extended treatment studies. J Child Adolesc Psychopharmacol1993;3:81–97.
19.
ShevellMSchreiberR. Pemoline-associated hepatic failure: A critical analysis of the literature. Pediatr Neurol1997;16:14–6.
20.
SilvaRRMunozDMAlpertM. Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: A meta-analysis. J Am Acad Child Adolesc Psychiatry1996;35:352–8.
21.
SpencerTBiedermanJWilensTHardingMO'DonnellDGriffinS. Pharmacotherapy of attention-deficit hyperactivity disorder across the life. J Am Acad Child Adolesc Psychiatry1996;35:409–32.
22.
SteinMAKrasowskiMLeventhalBLPhillipsWBenderBG. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Arch Pediatr Adolesc Med1996;150:284–8.
23.
ThurberSWalkerCE. Medication and hyperactivity: A meta-analysis. J Gen Psychol1983;108(lst Half):79–86.
24.
WilensT EBiedermanJSpencerT JPrinceJ. Pharmacotherapy of adult attention deficit/hyperactivity disorder: A review. J Clin Psychopharmacol1995;15:270–9.
25.
BiedermanJGonzalezEBronsteinBDeMonacoHWrightV. Desipramine and cutaneous reactions in pediatric outpatients. J Clin Psychiatry1988;49:178–83.
26.
BlumKSheridanPJWoodRCBravermanERChenTJComingsDE. Dopamine D2 receptor gene variants: Association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics1995;5:121–41.
27.
CampbellMCuevaJE. Psychopharmacology in child and adolescent psychiatry: A review of the past seven years: I. J Am Acad Child Adolesc Psychiatry1995;34:1124–32.
28.
DiamondGSSerranoACDickeyMSonisWA. Current status of family-based outcome and process research. J Am Acad Child Adolesc Psychiatry1996;35:6–l6.
29.
HillJCSchoenerEP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry1996;153:1143–6.
30.
LockJStraussGD. Psychiatric hospitalization of adolescents for conduct disorder. Hospital & Community Psychiatry1994;45:925–8.
31.
PetersonBS. Neuroimaging in child and adolescent neuropsychiatrie disorders. J Am Acad Child Adolesc Psychiatry1995;34:1560–76.
32.
PriestRGGimbrettRRobertsMSteinertJ. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. Acta Psychiatr Scand1995;(Suppl 386):40–3.
33.
RichtersJEArnoldIEJensenPSAbikoffHConnersCK, Greenhill LL, and others. NIMH Collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry1995;987–1000.
34.
SpencerTBiedermanJWilensTGuiteJHardingM. ADHD and thyroid abnormalities: A research note. J Child Psychol Psychiatry1995;36:879–85.
35.
SwansonJMMcBurnettKWigalTPfiffnerLJLernerMA, Williams L, and others. Effect of stimulant medication on children with attention deficit disorder: A “review of reviews.”Exceptional Children1993;60:154–62.
36.
WolraichMLWilsonDBWhiteJW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA1995;274:1617–21.
37.
CorkumPTannockRMoldofskyH. Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1998;37:637–46.
38.
CantwellDP. ADHD through the life span: The role of bupropion in treatment. J Clin Psychiatry1998;Suppl 4:4–94.
39.
MillerALeeSKRainaPKlassenAZupancicJOlsenL. A review of therapies for attention-deficit/hyperactivity disorder. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). RFP #ADHD-1196 http://www.ccohta.ca/main-e.html.
WilensTEBiedermanJSpencerTJ. Pharmacotherapy of attention deficit hyperactivity disorder in adults. CNS Drugs1998;May(5):347–56.
42.
CrenshawTM. Attention deficit hyperactivity disorder and the efficacy of stimulant medication: A meta-analysis. Dissertation. Abstracts. International.: Section. B.: The Sciences and Engineering1997;Sep(3-B):1524.
43.
SwansonJMMcBurnettKChristianDLWigalT. Stimulant medications and the treatment of children with ADHD. In: OllendickTHPrinzRJ, editors. Advances in clinical child psychology. Volume 17. New York: Plenum Press; 1995.
44.
MulrowCCookD. Systematic reviews: Synthesis of best evidence for health care decisions. Philadelphia: American College of Physicians; 1998.
45.
OxmanADGuyattGH. Guidelines for reading literature reviews. Can Med Assoc J1988;138:697–703.
46.
SacksHSBerrierJReitmanDPaganoDChalmersTC. Meta-analysis of randomized control trials. In: BailarJCMostellerF, editors. Medical uses of statistics. 2nd ed.Boston: NEJM Books; 1992.
